NYSE:KVUE

Kenvue (KVUE) Stock Price, News & Analysis

$20.60
+0.06 (+0.29%)
(As of 05:33 PM ET)
Today's Range
$20.51
$20.94
50-Day Range
$18.82
$21.46
52-Week Range
$17.82
$27.70
Volume
71.52 million shs
Average Volume
18.58 million shs
Market Capitalization
$39.45 billion
P/E Ratio
26.41
Dividend Yield
3.88%
Price Target
$24.38

Kenvue MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
17.3% Upside
$24.38 Price Target
Short Interest
Healthy
1.61% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.79mentions of Kenvue in the last 14 days
Based on 20 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
6.78%
From $1.18 to $1.26 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.22 out of 5 stars

Consumer Staples Sector

71st out of 137 stocks

Toilet Preparations Industry

5th out of 13 stocks

KVUE stock logo

About Kenvue Stock (NYSE:KVUE)

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

KVUE Stock Price History

KVUE Stock News Headlines

Johnson & Johnson is as Cheap as it’s Going to Get (KVUE)
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely.
Kenvue Announces Pricing of Secondary Offering
Kenvue Launches Secondary Offering Of 182.33 Mln Shares
Kenvue Announces Launch of Secondary Offering
Kenvue (NYSE:KVUE) PT Raised to $21.00
In-Depth Examination Of 7 Analyst Recommendations For Kenvue
See More Headlines
Receive KVUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/28 Dividend
2/13/2024
Dividend Payable
2/28/2024
Last Earnings
5/07/2024
Ex-Dividend for 5/22 Dividend
5/07/2024
Today
5/16/2024
Dividend Payable
5/22/2024
Next Earnings (Estimated)
7/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
N/A
Fax
N/A
Employees
22,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.38
High Stock Price Target
$30.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+18.7%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
16 Analysts

Profitability

Net Income
$1.66 billion
Pretax Margin
12.97%

Debt

Sales & Book Value

Annual Sales
$15.44 billion
Cash Flow
$1.59 per share
Book Value
$5.55 per share

Miscellaneous

Outstanding Shares
1,914,810,000
Free Float
1,911,556,000
Market Cap
$39.33 billion
Optionable
Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Thibaut Mongon (Age 53)
    CEO & Director
    Comp: $4.79M
  • Mr. Paul Ruh (Age 56)
    Chief Financial Officer
    Comp: $2.33M
  • Ms. Meredith Stevens (Age 61)
    Chief Operations Officer
    Comp: $1.84M
  • Mr. Carlton Lawson (Age 55)
    Group President of EMEA & Latin America
    Comp: $2.28M
  • Ms. Ellie Bing Xie (Age 54)
    Group President of Asia Pacific
    Comp: $2.94M
  • Ms. Heather R. Howlett (Age 46)
    Chief Accounting Officer
  • Mr. Bernardo Tavares (Age 56)
    Chief Data & Technology Officer
  • Dr. Caroline Tillett (Age 52)
    Chief Scientific Officer
  • Ms. Tina Romani
    Head of Investor Relations
  • Mr. Matthew Orlando (Age 47)
    General Counsel

KVUE Stock Analysis - Frequently Asked Questions

Should I buy or sell Kenvue stock right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last twelve months. There are currently 1 sell rating, 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.
View KVUE analyst ratings
or view top-rated stocks.

What is Kenvue's stock price target for 2024?

16 brokers have issued 12 month price targets for Kenvue's stock. Their KVUE share price targets range from $18.00 to $30.00. On average, they predict the company's share price to reach $24.38 in the next year. This suggests a possible upside of 17.3% from the stock's current price.
View analysts price targets for KVUE
or view top-rated stocks among Wall Street analysts.

How have KVUE shares performed in 2024?

Kenvue's stock was trading at $21.53 at the beginning of 2024. Since then, KVUE stock has decreased by 3.5% and is now trading at $20.78.
View the best growth stocks for 2024 here
.

Are investors shorting Kenvue?

Kenvue saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 27,800,000 shares, a decline of 22.8% from the April 15th total of 36,030,000 shares. Based on an average daily trading volume, of 17,630,000 shares, the days-to-cover ratio is currently 1.6 days. Currently, 1.6% of the shares of the stock are sold short.
View Kenvue's Short Interest
.

When is Kenvue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 18th 2024.
View our KVUE earnings forecast
.

How were Kenvue's earnings last quarter?

Kenvue Inc. (NYSE:KVUE) issued its quarterly earnings data on Tuesday, May, 7th. The company reported $0.28 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.03. The company earned $2.89 billion during the quarter, compared to analyst estimates of $3.79 billion. Kenvue had a net margin of 9.63% and a trailing twelve-month return on equity of 21.06%. The firm's revenue for the quarter was down 24.9% on a year-over-year basis.

How often does Kenvue pay dividends? What is the dividend yield for Kenvue?

Kenvue announced a quarterly dividend on Thursday, April 25th. Shareholders of record on Wednesday, May 8th will be given a dividend of $0.20 per share on Wednesday, May 22nd. This represents a $0.80 annualized dividend and a yield of 3.85%. The ex-dividend date is Tuesday, May 7th.
Read our dividend analysis for KVUE
.

Is Kenvue a good dividend stock?

Kenvue (NYSE:KVUE) pays an annual dividend of $0.80 per share and currently has a dividend yield of 3.93%. The dividend payout ratio is 102.56%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, KVUE will have a dividend payout ratio of 63.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for KVUE.

What guidance has Kenvue issued on next quarter's earnings?

Kenvue updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share guidance of 1.100-1.200 for the period, compared to the consensus earnings per share estimate of 1.140. The company issued revenue guidance of $15.6 billion-$15.9 billion, compared to the consensus revenue estimate of $15.6 billion.

When did Kenvue IPO?

Kenvue (KVUE) raised $3.3 billion in an initial public offering on Thursday, May 4th 2023. The company issued 151,200,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank acted as the underwriters for the IPO.

Who are Kenvue's major shareholders?

Kenvue's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.71%), Price T Rowe Associates Inc. MD (7.03%), JPMorgan Chase & Co. (3.57%), Bank of New York Mellon Corp (1.87%), Capital International Investors (1.19%) and Nordea Investment Management AB (0.61%).
View institutional ownership trends
.

How do I buy shares of Kenvue?

Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:KVUE) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners